iPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies.
iPSCs
intestine-on-a-chip
liver-on-a-chip
organ-on-a-chip
personalized medicine
pharmacogenomics
vessel-on-a-chip
Journal
Trends in genetics : TIG
ISSN: 0168-9525
Titre abrégé: Trends Genet
Pays: England
ID NLM: 8507085
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
13
07
2022
revised:
24
11
2022
accepted:
12
01
2023
pubmed:
7
2
2023
medline:
24
3
2023
entrez:
6
2
2023
Statut:
ppublish
Résumé
Genome-wide association studies (GWAS) have now correlated hundreds of genetic variants with complex genetic diseases and drug efficacy. Functional characterization of these factors remains challenging, particularly because of the lack of human model systems. Molecular and nanotechnological advances, in particular the ability to generate patient-specific PSC lines, differentiate them into diverse cell types, and seed and combine them on microfluidic chips, have led to the establishment of organ-on-a-chip (OoC) platforms that recapitulate organ biology. OoC technology thus provides unique personalized platforms for studying the effects of host genetics and environmental factors on organ physiology. In this review we describe the technology and provide examples of how OoCs may be used for disease modeling and pharmacogenetic research.
Identifiants
pubmed: 36746737
pii: S0168-9525(23)00017-3
doi: 10.1016/j.tig.2023.01.002
pii:
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
268-284Informations de copyright
Copyright © 2023. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of interests No interests are declared.